Drug Therapy for Acute Ischaemic Stroke: Risks versus Benefits

ISSN： 0114-5916

Source： Drug Safety, Vol.19, Iss.5, 1998-11, pp. : 373-382

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Optimal Timing of Thrombolytic Therapy in Acute Ischaemic Stroke

By Madden K.

CNS Drugs, Vol. 16, Iss. 4, 2002-01 ,pp. : 213-218

Adis International

Access to resources Recommend Favorite

Neuroprotection and thrombolysis: combination therapy in acute ischaemic stroke

By Ly John V Zavala Jorge A Donnan Geoffrey A

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 12, 2006-08 ,pp. : 1571-1581

Informa Healthcare

Access to resources Recommend Favorite

The risks associated with alteplase therapy do not appear to be higher in selected patients aged 80 years with acute ischaemic stroke, compared with younger patients

Inpharma, Vol. 1, Iss. 1228, 2000-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Risks Versus Benefits of Testosterone Therapy in Elderly Men

By Basaria S. Dobs A.S.

Drugs & Aging, Vol. 15, Iss. 2, 1999-08 ,pp. : 131-142

Adis International

Access to resources Recommend Favorite

Clinical Potential of Intra-Arterial Thrombolytic Therapy in Patients with Acute Ischaemic Stroke

By Xavier A.R.

CNS Drugs, Vol. 17, Iss. 4, 2003-01 ,pp. : 213-224

Adis International

Access to resources Recommend Favorite